Guest guest Posted May 13, 2011 Report Share Posted May 13, 2011 Friday May 13, 2011 Boceprevir Wins FDA Approval to Treat Hepatitis C WASHINGTON -- The FDA has approved the investigational drug boceprevir (Victrelis), in combination with peginterferon and ribavirin, to treat hepatitis C genotype 1, making it the first HCV protease inhibitor to reach market.http://www.medpagetoday.com/InfectiousDisease/Hepatitis/26469?utm_source=breaking-news & utm_medium=email & utm_campaign=breaking-news You have received this email because you have registered to receive alert emails atwww.medpagetoday.com, with the email address: ludichrist2000@....TECHNICAL QUESTIONS:webmaster@... MedPage Today, LLC. - Overlook at Great Notch - 150 Clove Road - Little Falls, New Jersey 07424 - Tel: (973) 890-0985 - Fax: (973) 890-1327 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.